Axiom Biosciences
PrivateLast Round
Series A
Dec 4, 2023
Total Funding Raised
$19.42M
Company Overview
Axiom Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series A round in December 2023.
Axiom Biosciences is a biotechnology company that develops next-generation regenerative therapies and targeted biologics by integrating cell therapy programs with AI-enabled drug design.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axiom Biosciences Comparables
Compare Axiom Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medinno | 76% | |
| Alevian, Inc. | 71% | |
| ReAlta Life Sciences | 69% |
For institutional investors. Book with your work email.
Axiom Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 4, 2023 | ||||
| Grant | Aug 31, 2023 | ||||
| VC Round | Feb 28, 2023 | ||||
| Seed | Jul 29, 2022 | ||||
| Grant | Mar 1, 2021 | ||||
Convertible Debt | Mar 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axiom Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KreaMedica Holdings | Series A |
| Creative Ventures | Series A |
| WS Investment Company | Series A |
| Partners Investment | Series A |
| Proxima Ventures Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 361% MoM.
- Apr 6, 2026
Monthly visitors grew 74% MoM, from 605 to 1.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 12, 2026
Axiom Bio is developing advanced therapeutics for difficult-to-treat conditions, including a lead regenerative medicine program for severe brain injuries in newborns and targeted delivery technologies for localizing biologic therapies at disease sites.
- partners_withSep 15, 2026
Axiom Bio and GeneFab form a strategic partnership to expand manufacturing and clinical development capabilities and support Axiom Bio's therapeutic pipeline in California on Sep 15th '26.
For institutional investors. Book with your work email.
Axiom Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axiom Biosciences's valuation, stock price, and market status.
Is Axiom Biosciences a public or private company?
Axiom Biosciences is a private company.
What is the current stock price of Axiom Biosciences?
Axiom Biosciences is a private company, so its shares have no public market price. Caplight tracks Axiom Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axiom Biosciences worth (valuation)?
Valuation information for Axiom Biosciences is not publicly available.
Can I buy Axiom Biosciences stock?
Axiom Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axiom Biosciences's last funding round?
Axiom Biosciences's most recent funding round was Series A on December 4, 2023.
Who are the main investors in Axiom Biosciences?
Key investors in Axiom Biosciences include Partners Investment.
Will Axiom Biosciences IPO soon?
No public IPO plans have been announced for Axiom Biosciences.
How can I track Axiom Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Axiom Biosciences's shares on secondary markets.